Viewing Study NCT04184518


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:58 AM
Study NCT ID: NCT04184518
Status: WITHDRAWN
Last Update Posted: 2020-06-02
First Post: 2019-11-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma
Sponsor: Grupo EspaƱol Multidisciplinar de Melanoma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module